12-18 January 2010

 

Previous edition
January, 05-11
 
Upcoming Events
26-27 January - ADME, PK/TK and Drug Metabolism in Drug Discovery and Development, Brussels, Belgium
26 - 27  January  EFGCP Annual Conference 2010 - Aspects of Personalised Medicine for Society - A Challenge Yet to be Met,  Brussels, Belgium
1 - 2 February Biosquare 2010, Geneva, Switzerland
 

Suscribe to our RSS feed
 

Follow us


Twitter
 


Facebook
 

Watch our videos on Youtube

Join us on Facebook

 

EuropaBio Weekly
subscribe EuropaBio Weekly
unsubscribe EuropaBio Weekly


EuropaBio
Avenue de l'Armée 6
B-1040 Brussels, Belgium
Tel: +32 2 735 03 13
Fax: +32 2 735 49 60

http://www.europabio.org

              
If you can not read this newsletter, click here

 

Headlines

 

Britain must launch GM food revolution, says chief scientist
Britain must embrace genetically modified crops and cutting-edge developments such as nanotechnology to avoid catastrophic food shortages and future climate change, the government's chief scientist warned last week.
 

 
  Bio-based Economy Gets $171 Million Stimulus from Dutch BE-Basic Consortium
As of January 1st 2010, knowledge institutes, the Dutch government and industry are to cooperate more intensively and at international level to speed up the introduction of the bio-based economy, an economy based on renewable sources.
 
 
  EuropaBio Publication - Socio-economic impacts of green biotechnology
 
 
 

Green Biotech (top)

  Quiet Biotech Revolution Transforming Crops
For the past two decades, promises of crop improvement have been the domain of genetically modified plants: mostly, crops supplemented with bacterial genes to resist pests or weedkillers like Roundup. More than 85 percent of U.S. corn, soy or cotton grown contains such genes.
 
 
 

Red Biotech (top)

  Study uncovers costs of drug resistance for bacteria 
Developing resistance to certain antibiotics may come at a price for the bacteria, new Swedish research suggests. Sara Thulin Hedberg of Örebro University studies the bacteria Neisseria meningitidis, one of the main causes of meningitis. She found that bacteria that are resistant to the drug rifampicin do not reproduce as fast as non-resistant bacteria and are not as good at infecting people. She hopes that her findings, which form part of her doctoral dissertation, will lead to the development of new, more effective antibiotics. 

 
 
  Stem Cells Likely to Help Genetic Disorders First
Drugs developed without animal testing could be one result, some predict. With new rules in place that lifted restrictions on federal funding of human embryonic stem cell research, health-care advocates are looking down the line and wondering when the first medical advances based on stem cells might occur.
 
 
 

White Biotech (top)

 

Genetically Engineered Tobacco Plants: A Promising Source for Biofuel
Researchers from the Biotechnology Foundation Laboratories at Thomas Jefferson University have discovered a way to bring about an increase in the oil present in the leaves of the tobacco plant. This discovery may be considered as the next step to use the tobacco plants as a source for biofuel. The research paper was published in Plant Biotechnology Journal.

 

 
 

Other (top)